national research program for biopharmaceuticals
Glaxo & Taiwan’s NRPB Sign Clinical Trial Research Pact
Taiwan’s National Research Program for Biopharmaceuticals signed yesterday an MOU with GlaxoSmithKline to develop Taiwan as a clinical trial hub in Asia.



